Clinical activity and safety of anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced melanoma (MEL).
暂无分享,去创建一个
J. Sosman | F. Hodi | M. Sznol | J. Wigginton | A. Gupta | S. Topalian | R. Carvajal | D. Lawrence | G. Kollia | D. McDermott | D. McDonald